Benzamidenafil
 | |
| Names | |
|---|---|
| IUPAC name
N-[(3,4-Dimethoxyphenyl)methyl]-2-(1-hydroxypropan-2-ylamino)-5-nitrobenzamide | |
| Other names
Xanthoanthrafil | |
| Identifiers | |
| 1020251-53-9 | |
| 3D model (Jmol) | Interactive image |
| ChemSpider | 8286399 |
| MeSH | C442640 |
| PubChem | 10110873 |
| |
| |
| Properties | |
| C19H23N3O6 | |
| Molar mass | 389.41 g·mol−1 |
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
| Infobox references | |
Benzamidenafil is a synthetic drug that acts as a PDE5 inhibitor. It has the same mechanism of action as pharmaceutical drugs used to treat erectile dysfunction, but it is not approved by any regulatory agency for such use.[1] It has been found as an undeclared adulterant in supposedly "natural" health supplements.[1][2] In 2009, the supplement manufacturer Hi-Tech Pharmaceuticals recalled its product Stamina-Rx because it was adulterated with benzamidenafil.[3]
References
- 1 2 Rica Lewis (Aug 16, 2013). "Stamina Rx Ingredients".
- ↑ "Identification of benzamidenafil, a new class of phosphodiesterase-5 inhibitor, as an adulterant in a dietary supplement". Journal of Pharmaceutical and Biomedical Analysis. 47 (2): 255–259. doi:10.1016/j.jpba.2008.01.004.
- ↑ "FDA MedWatch – Stamina-Rx Dietary Supplement Products". Vanderbuilt University.
This article is issued from Wikipedia - version of the 11/29/2014. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.